CVS Health Co. (NYSE:CVS – Get Free Report) was the recipient of some unusual options trading on Thursday. Investors purchased 122,130 put options on the company. This is an increase of 134% compared to the average daily volume of 52,206 put options.
Analyst Ratings Changes
CVS has been the topic of a number of recent research reports. Barclays dropped their price objective on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Piper Sandler dropped their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a report on Monday, November 25th. UBS Group increased their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a research report on Tuesday, October 1st. Finally, Truist Financial reiterated a “buy” rating and set a $67.00 price target (down from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $69.12.
Check Out Our Latest Report on CVS Health
Institutional Investors Weigh In On CVS Health
CVS Health Stock Up 1.5 %
NYSE CVS traded up $0.67 on Thursday, reaching $44.92. The company had a trading volume of 11,265,004 shares, compared to its average volume of 11,649,337. The firm has a 50-day moving average of $54.92 and a 200-day moving average of $57.85. CVS Health has a 1 year low of $43.56 and a 1 year high of $83.25. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm has a market capitalization of $56.53 billion, a PE ratio of 11.40, a P/E/G ratio of 0.85 and a beta of 0.54.
CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The firm had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. During the same quarter in the prior year, the business posted $2.21 earnings per share. CVS Health’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities research analysts anticipate that CVS Health will post 5.32 EPS for the current fiscal year.
CVS Health Company Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
- Five stocks we like better than CVS Health
- The 3 Best Retail Stocks to Shop for in August
- Top 3 Investment Themes to Watch for in 2025
- What is the Shanghai Stock Exchange Composite Index?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How to Invest in the Best Canadian StocksĀ
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.